CAS 1408064-71-0

Benzamide, 3-[[4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-N-[4-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-

CAS : 1408064-71-0

Formule : C₂₈H₂₇N₇O₂

Degré de pureté : 99%

Couleur et forme : Solid

Masse moléculaire : 493.5597

Ref: IN-DA001CS6

JNK-IN-7

CAS : 1408064-71-0

JNK-IN-7

Formule : C₂₈H₂₇N₇O₂

Degré de pureté : 99.0% (Typical Value in Batch COA)

Couleur et forme : yellow solid

Masse moléculaire : 493.56g/mol

Ref: 54-BISN0187

JNK-IN-7

CAS : 1408064-71-0

JNK-IN-7

Degré de pureté : ≥98%

Masse moléculaire : 493.56g/mol

Ref: 54-BUP02553

JNK-IN-7

CAS : 1408064-71-0

JNK-IN-7 (JNK inhibitor) is a selective JNK1/2/3 inhibitor (IC50: 1.54/1.99/0.75 nM).

Formule : C₂₈H₂₇N₇O₂

Degré de pureté : 98.02% - 99.53%

Couleur et forme : Solid

Masse moléculaire : 493.56

Ref: TM-T3598

JNK-IN-7

CAS : 1408064-71-0

JNK-IN-7 is a compound that inhibits the activity of a kinase enzyme, specifically c-Jun N-terminal kinase (JNK). JNK-IN-7 is a potential drug for bowel disease and injury. It has been shown to inhibit the inflammatory response in animal models by inhibiting the activation of transcription factor NFκB, and blocking the production of proinflammatory cytokines. JNK-IN-7 has antiinflammatory activity and can be used as an inhibitor in certain diseases such as Crohn's disease, ulcerative colitis, or IBD. The molecule also blocks the production of proteins that are involved in inflammation pathways.

Formule : C₂₈H₂₇N₇O₂

Degré de pureté : Min. 95%

Masse moléculaire : 493.56 g/mol

Ref: 3D-IGC06471